27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Abbott Laboratories (NYSE:ABT) reported third-quarter earnings of 84 cents per share, which met the analyst consensus estimate. This is a 12% increase over earnings of 75 cents per share from the same period last year.
The company reported quarterly sales of $8.076 billion, which missed the analyst consensus estimate of $8.11 billion by 0.42%. This is a 5.49% increase over sales of $7.656 billion the same period last year.
"We're performing exceptionally well across several areas," said Miles White, CEO of Abbott. "We're right on track to achieve ongoing EPS and organic sales growth at the upper-end of our initial guidance ranges for the year."
Abbott Laboratories shares were trading down 1.8% at $80.50 in Wednesday’s pre-market session. The stock has a 52-week high of $88.76 and a 52-week low of $65.44.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!